Ludmilla de Plater - Concepedia

Author

Ludmilla de Plater

Also Known As

L DE PLATER, L De Plater, L de Plater, L. De Plater, L. de Plater, Ludmilla D. Plater, Ludmilla De PLATER, Ludmilla De Plater, Ludmilla de Plater

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Institut Curie Inserm Université Paris Sciences et Lettres Centre National de la Recherche Scientifique École Nationale Vétérinaire d'Alfort

About

Ludmilla de Plater is an author at Institut Curie specializing in medicine, radiation oncology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	111
2	Public Health	1	1	17
3	Cell Biology	1	1	17
4	Cellular Physiology	1	1	17
5	Endocrinology	1	1	94

Ludmilla de Plater

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
A New Model of Patient Tumor-Derived Breast Cancer Xenografts for Preclinical Assays Elisabetta Marangoni, Anne Vincent‐Salomon, Nathalie Auger, Clinical Cancer Research	2007	405
Hydraulic fracturing and active coarsening position the lumen of the mouse blastocyst Julien G. Dumortier, Mathieu Le Verge-Serandour, Anna Francesca Tortorelli, Science	2019	245
Molecular profiling of patient-derived breast cancer xenografts Fabien Reyal, Charlotte Guyader, Charles Decraene, Breast Cancer Research	2012	188
Modeling of response to endocrine therapy in a panel of human luminal breast cancer xenografts Paul Cottu, Elisabetta Marangoni, Franck Assayag, Breast Cancer Research and Treatment Breast OncologyEndocrine MechanismMedicinePharmacologyBreast Cancer	2011	94
Capecitabine Efficacy Is Correlated with TYMP and RB1 Expression in PDX Established from Triple-Negative Breast Cancers Elisabetta Marangoni, Cécile Laurent, Florence Coussy, Clinical Cancer Research	2018	63
Targeting Bcl-2/Bcl-XL Induces Antitumor Activity in Uveal Melanoma Patient-Derived Xenografts Fariba Némati, Catherine de Montrion, Guillaume Lang, PLoS ONE	2014	49
Establishment and characterisation of a new breast cancer xenograft obtained from a woman carrying a germline BRCA2 mutation Ludmilla de Plater, Anthony Laugé, Charlotte Guyader, British Journal of Cancer	2010	44
Vandetanib as a potential new treatment for estrogen receptor‐negative breast cancers Rana Hatem, Dalila Labiod, Sophie Château‐Joubert, International Journal of Cancer	2015	41
Targeting mTOR pathway inhibits tumor growth in different molecular subtypes of triple-negative breast cancers Rana Hatem, Rania El Botty, Sophie Château‐Joubert, Oncotarget	2016	35
Multiscale analysis of single and double maternal-zygotic Myh9 and Myh10 mutants during mouse preimplantation development Markus Frederik Schliffka, Anna Francesca Tortorelli, Özge Özgüç, eLife	2021	29

Page 1